BioSpace News Archive

Asklepios BioPharmaceutical , Inc. announced that the U.S. Food & Drug Administration (FDA) has granted Fast Track Designation for the LION-101 gene therapy program.

Psyence Group Inc. is pleased to announce that it has appointed Dr. Neil Maresky as Chief Executive Officer.

Bellicum Pharmaceuticals, Inc. today announced it has entered into a license agreement with the University of North Carolina Lineberger Comprehensive Cancer Center (UNC Lineberger) and Massachusetts General Hospital (Mass General) covering certain intellectual property and technology rights regarding the company’s CaspaCIDe safety switch.

OpGen, Inc . today announced that its subsidiary Ares Genetics presented an update on the company’s R&D pipeline during two virtual seminars held on May 22 and on May 24, 2021.

Crinetics Pharmaceuticals, Inc. today announced the randomization of the first acromegaly patient in its Phase 3 clinical trial of paltusotine, PATHFNDR-1 Study.

Pinteon Therapeutics today announced positive results from its Phase 1 study of PNT001.

9 Meters Biopharma, Inc. announced today it has joined the broad-market Russell 3000 Index and the small-cap Russell 2000 Index at the conclusion of the Russell U.S. Indexes annual reconstitution.

Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced the appointment of Eron S. Kelly as its Corporate President.

Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers, today announced the appointment of Helen Sabzevari, Ph.D. to its Board of Directors.

Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced today that the OraGrowtH212 Trial, a Phase 2 PK/PD study of the company’s lead asset LUM-201 for the treatment of patients with pediatric growth hormone deficiency (PGHD), is open for enrollment.